GlassScriptPhysician profile
Jason C Miller
NPI 1164411021
$47,952.38
in general payments reported to CMS, 2019-2025
26 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $353 · 2021: $43K · 2022: $339 · 2023: $207 · 2024: $2,855 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2,577 · Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,577.34 |
| Food and Beverage | $837.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $40,051.65 | 2021 | |
| Dne LLC | $2,782.00 | 2021 | |
| Restor3d, INC. | $2,577.34 | 2024 | |
| Stryker Corporation | $614.33 | 2019-2025 | Augment Injectable |
| Sanara Medtech INC. | $277.30 | 2021 | |
| Smith+Nephew, INC. | $257.67 | 2024 | Grafix Pl, Stravix Pl, Oasis Micro |
| Trilliant Surgical LLC. | $228.82 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $160.49 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $144.32 | 2020 | |
| Bone Support INC. | $120.62 | 2025 | Cerament G, Ceramentbone Void Filler |
| Medtronic, INC. | $103.46 | 2023 | Intellis Adaptivestim |
| Wound Management Technologies, INC | $93.93 | 2019 | |
| Celularity INC. | $76.00 | 2019 | |
| Melinta Therapeutics, LLC | $59.76 | 2019-2021 | |
| Bioventus LLC | $57.62 | 2024-2025 | Exogen Ultrasound Bone Healing System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $45.48 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $45.48 | 2022 | |
| Acera Surgical, INC. | $40.37 | 2020-2023 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $40.12 | 2025 | |
| Encore Medical, LP | $37.08 | 2021 | |
| Alexion Pharmaceuticals, INC. | $28.05 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $24.88 | 2019 | |
| Biotissue Holdings INC. | $24.25 | 2021 | |
| Integra Lifesciences Corporation | $22.00 | 2019 | |
| Heron Therapeutics, INC. | $21.34 | 2021 | |
| Janssen Biotech, INC. | $18.02 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.